ETOILE: Real-World Evidence of 24 Months of Ranibizumab 0.5 mg in Patients with Visual Impairment Due to Diabetic Macular Edema

ETOILE: Real-World Evidence of 24 Months of Ranibizumab 0.5 mg in Patients with Visual Impairment Due to Diabetic Macular Edema

Laurent Kodjikian,1 Amélie Lecleire-Collet,2 Corinne Dot,3 Marie-Laure Le Lez,4 Stéphanie Baillif,5 Ali Erginay,6 Eric Souied,7 Eric Fourmaux,8 Philippe Gain,9 Anne Ponthieux10 1Department of Ophthalmology, Croix-Rousse University Hospital, Lyon, France; 2Mathilde Clinic, Rouen...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Kodjikian L, Lecleire-Collet A, Dot C, Le Lez ML, Baillif S, Erginay A, Souied E, Fourmaux E, Gain P, Ponthieux A
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2021
Materias:
real-world study
retinal thickness
visual acuity
switch
induction
Ophthalmology
RE1-994
Acceso en línea:https://doaj.org/article/50aa141a92864c05904cba97ca928361
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/50aa141a92864c05904cba97ca928361

Ejemplares similares